pharmaceutical composition, use of a composition of matter, and use of a therapeutically effective combination of a survivin antisense oligonucleotide and gemcitabine hydrochloride

摘要

PHARMACEUTICAL COMPOSITION, USE OF A MATERIAL COMPOSITION, AND USE OF A THERAPEUTICALLY EFFICIENT COMBINATION OF A SURVIVINE ANTI-SENSE OLIGONUCLEOTIDE AND GEMCITABINE CHLORIDRATE. The present invention relates to a method of treating cancer in a patient comprising administering an effective amount of a Survivin antisense oligonucleotide in combination with an effective amount of an additional anti-cancer agent.